Sheel Biotech LimitedSHEELCorporate

Latest results: Sep 2025 1 quarters of data
—
MCap —
Live price not available
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹22 Cr
Sales · Sep 2025
₹2 Cr
Operating Profit · Sep 2025
8.1%
OPM % · Sep 2025
₹0 Cr
Net Profit · Sep 2025
₹0.13
EPS · Sep 2025

📝 Sheel Biotech Limited — results explained

Quarter ended September 2025 (Q2 FY26)

Sheel Biotech Limited reported revenue of ₹22 crore for the quarter ended September 2025 (Q2 FY26).

Net profit stood at ₹0 crore. Earnings per share (EPS) came in at ₹0.13.

Operating profit stood at ₹2 crore — an operating margin (OPM) of 8.1%.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
N/A
Current Price ?
N/A
P/E ?
N/A
Industry P/E ?
N/A
P/B ?
N/A
P/S ?
N/A
P/FCF ?
N/A
Enterprise Value ?
N/A
EV/EBITDA ?
N/A
PEG ?
N/A
Earnings Yield ?
N/A
Dividend Yield ?
N/A
Profitability & Returns
Sales (TTM) ?
N/A
OPM ?
N/A
Profit after tax (TTM) ?
N/A
EPS (TTM) ?
N/A
ROCE ?
N/A
ROE ?
N/A
ROA ?
N/A
Growth
Sales — latest qtr ?
₹22 Cr
PAT — latest qtr ?
₹0 Cr
YoY qtr sales growth ?
N/A
YoY qtr profit growth ?
N/A
Sales growth (3y) ?
N/A
Sales growth (5y) ?
N/A
Profit growth (3y) ?
N/A
Profit growth (5y) ?
N/A
Financial Health
Debt ?
N/A
Debt to Equity ?
N/A
Interest Coverage ?
N/A
Current Ratio ?
N/A
Ownership
Promoter holding ?
N/A
Change in promoter holding ?
N/A
Pledged percentage ?
N/A
Market
Return 3 months ?
N/A
Return 6 months ?
N/A

🗓️ Quarterly results (1 quarters · ₹ Cr)

same fiscal quarter as Sep bestweakest per row · for costs (interest, NPAs) low is best
Metric Sep 2025 YoY % QoQ %
Sales 22 — —
Operating Profit 2 — —
Other Income 0 — —
Interest 1 — —
Depreciation 1 — —
Profit Before Tax 0 — —
Net Profit 0 — —
EPS 0.13 — —
OPM % 8.1% — —

📆 Annual results (₹ Cr, FY = Apr–Mar)

Annual rollup not yet available We need at least 3 quarters of a fiscal year to compute annual figures. This symbol does not yet have a complete fiscal year in our database.

⚖️ Peer comparison

Peer comparison unavailablePeer comparison unavailable — industry and sector are not classified for this symbol.
❓ Frequently asked questions
What was Sheel Biotech Limited's revenue in Q2 FY26?
Sheel Biotech Limited reported revenue of ₹22 crore for the quarter ended September 2025 (Q2 FY26).
What was Sheel Biotech Limited's net profit in Q2 FY26?
Net profit stood at ₹0 crore. Earnings per share (EPS) came in at ₹0.13.
TTM ends N/A. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI